Biotech

All Articles

Gene publisher Tome laying off 131 employees

.Only days after gene publisher Volume Biosciences declared undisclosed functional slices, a more cl...

Repare lays off 25% of staff as biotech stops preclinical R&ampD

.Repare Rehab is giving up a fourth of its own workforce as the oncology biotech scales back its pre...

J &amp J files for FDA permission of $6.5 B autoimmune medication

.Johnson &amp Johnson has actually gotten yet another measure towards understanding a yield on its o...

Gain's period 1 succeed paves way to verify Parkinson's drug's worth

.Increase Therapeutics has actually set its direct showing the efficiency of its own Parkinson's ail...

Actinogen reports brand-new phase 2 data to save depression medicine

.Actinogen Medical's chances-- and stock price-- have rebounded a little coming from earlier this mo...

Pfizer as well as Flagship incorporate Quotient to multibillion-dollar equation

.Crown Jewel Pioneering and Pfizer have actually added Quotient in to their 10-program partnership, ...

Bayer markers $547M deal to press boundaries of noncoding RNA

.Bayer managers were actually keen to stress to Ferocious this summer that the German pharma giant's...

UK introduces programs to release 18 new clinical test centers

.Amid a yearslong medical trial downtrend in the U.K., a brand new public-private partnership has de...

UPDATE: Genentech telegrams 93 cutbacks in California after discussing strategies to shutter cancer cells immunology study unit

.Complying with the news of a large discharge shot in April as well as a significant rebuilding camp...

Neurocrine's KarXT opponent hits in period 2-- but merely at low dosage

.Neurocrine Biosciences has actually accomplished its hoped-for profile in a phase 2 schizophrenia t...